Company / Income Tax per Share
BIOCRYST PHARMACEUTICALS INC Income Tax per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Income Tax per Share
$0.02
FY2025
5-year range
$0.00 / $0.02
FY2021-FY2025
Trend
+73.2%
vs FY2024
Sector context
#71 of 201
Health Care
What the data says
At $0.02, BIOCRYST PHARMACEUTICALS INC's income tax per share ranks #131 of 201 in the Health Care sector. Increased from $0.00 to $0.02 over the past 2 years.
Based on SEC 10-K filings.
0.02 in FY2025 with a 3-year CAGR of +3.2%.
Increased from $0.00 to $0.02 over the past 2 years.
Health Care sector context is included.
Income Tax per Share over time
Growth rates
- 3-Year CAGR
- +3.2%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#131 of 201 in Health CareTop 65% of 201This company $0.02 Sector average $1.35
▼
-98.8% below sector average
Key checks
Key Insights
- In FY2025, income tax per share increased 73.2% year-over-year.
- Ranks #71 out of 201 companies in the Health Care sector.
- Lowest income tax per share in the period was in FY2020.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Income Tax per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.02 | +73.2% |
| FY2024 | $0.01 | +478.0% |
| FY2023 | $0.00 | -89.0% |
| FY2022 | $0.01 | +16.9% |
| FY2021 | $0.01 | - |
| FY2020 | $0.00 | - |
| FY2019 | $0.00 | - |
| FY2018 | $0.00 | - |
| FY2017 | $0.00 | - |
| FY2016 | $0.00 | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026